HIV / Gilead Sciences / WebMD / National Public Radio / Los Angeles Times / Antiviral / /
Country
United States / /
Event
M&A / /
Facility
FDA’s Center / University of Washington / /
IndustryTerm
care for people living with the disease / HIV prevention / other HIV prevention / demonstration products / social network / media lists / /
MedicalCondition
HIV infection / disease / sexual acquired HIV infection / HIV infections / sexually transmitted infections / sexually inquired HIV infection / AIDS / infection / infections / /
MedicalTreatment
antiretroviral therapies / counseling / /
Organization
University of Washington / US government / FDA / office of Antimicrobial Products / FDA’s Center for Drug Evaluation and Research / FDA’s office of Public Affairs / Centers for Disease Control and Prevention / /
Person
Jeffrey Murray / Erica Jefferson / Debbie Birnkrant / Daniel Denoon / Debra Birnkrant / Richard Knox / Sue Sutter / Bob Roehr / Ian Duncan / Bob Reohr / Edward Cox / /
Position
director of the Division of Antiviral Products / Coordinator / director / deputy director of the Division / deputy director of the Division of Products / /
Page 1 of 17 Transcript of FDA’s Media Briefing on the Approval of Truvada for Pre-Exposure Prophylaxis (PrEP) Moderator: Erica Jefferson July 16, 2012